• CLINICAL INTEREST SECTIONS: Congenital Coronary Peripheral SCAI TAVR Center

  • SCAI This Week
  • March 8, 2012

    In This Issue:

     


     

     


     

    SCAI 2012: Dr. Julio Palmaz to Deliver Mullins Lecture on May 10

    When Julio C. Palmaz, MD, began his ground-breaking work on balloon-expandable stents in the late 1970s, he wasn't thinking of sick kids. But thanks to his spirit of innovation and a fruitful collaboration with pediatric cardiology pioneer Charles E. Mullins, MD, FSCAI, Dr. Palmaz forever changed the lives of children with congenital heart disease.

    Dr. Palmaz will deliver the Mullins Lecture at the SCAI 2012 Scientific Sessions, recounting how the same devices envisioned for use in coronary arteries and peripheral vessels in adults have transformed pediatric cardiology and allowed less invasive treatment of pulmonary artery stenosis, coarctation of the aorta, and other congenital heart defects.

    "Congenital heart disease is one of the most critical, risky, and difficult challenges in medicine," said Dr. Palmaz, a professor of radiology and Ashbel Smith Professor at the University of Texas Health Science Center at San Antonio. "People dedicated to treat children with these problems combine very hard work, resourcefulness, and passion. Chuck Mullins is the ultimate example of this, and I was lucky to share some early stent work in this area with him."

    During his keynote, Dr. Palmaz will also discuss how continued advancement in stent technology will be slower, more challenging, and more expensive than past achievements and how developers will need to move past mere refinements in existing stent design to take advantage of micro and nanotechnology to target molecular surface interactions.

    The next wave of innovation in stent technology could chart a new course in medical devices, he predicted. "The landscape of potential innovations is broader than it appears," Dr. Palmaz said. "There are technologies available today for vascular device development that are far removed from those in current use. By pursuing these developments, we may pave the way for innovations other than stents, such as implantable artificial organs and risk monitoring devices."

    Register Now for SCAI 2012 Scientific Sessions

    Find Out More About the CHD Symposium at SCAI 2012

    Download the Advance Program

    Back to Top


    SCAI President Dr. Christopher White Calls Out SVS on CAS Guideline

    Christopher J. White, MD, FSCAI spoke out last week about a guideline published by the Society for Vascular Surgery (SVS) on the management of patients with extracranial carotid and vertebral artery disease. SVS's guideline was released just months after it and 13 other societies, including SCAI, jointly published a guideline on the same condition.

    Dr. White was interviewed by theheart.org in advance of a President's Page slated to appear in Catheterization & Cardiovascular Interventions (CCI) later this month. In the editorial, Dr. White discusses the challenges inherent in writing guidelines that bridge specialties and the expectations of partners.

    He told theheart.org: "To get 14 societies together [on the multispecialty guideline] was a huge victory. I'm not 100% happy with the guideline, either. I think that carotid stenting is much more favorable in some populations than that guideline says, but we had to negotiate to keep those SVS guys at the table. They weren't going to sign off on what I like. . . . So they negotiated me away from what I like, and then six months later publish their own guideline anyway. Now why do I take them seriously at the negotiating table?"

    Stay tuned to read the President's Page in CCI.

    Back to Top


    Society Launches Interventional Heart Failure Working Group

    SCAI's Board of Trustees recently approved the formation of an Interventional Heart Failure (IHF) Working Group led by chair James Goldstein, MD, FSCAI, and co-chairs Morton Kern, MD, FSCAI and Srihari S. Naidu, MD, FSCAI.

    IHF, a novel concept, focuses on a heart team-based approach of clinical, advanced imaging, interventional, electrophysiologic, and heart failure cardiologists, as well as cardiothoracic surgeons, managing complicated heart failure cases, which may require not only medical therapy, but also high-risk complex PCI, with hemodynamic support devices, TAVR, implantable devices to monitor or treat heart failure, and open surgical procedures.

    Conceived and promoted by SCAI's IHF Working Group, two sessions at this year's ACC Annual Sessions and a formal launch session at SCAI 2012 Scientific Sessions will focus on multi-disciplinary management of the failing heart, particularly on interventional and other device-based mechanisms to comprehensively and sequentially treat patients with refractory or severe heart failure. The sessions encompass a full morning of programming on Monday, March 26, 2012 at the ACC Sessions in Chicago and a two-hour dedicated program on Wednesday, May 9, 2012 at SCAI 2012 in Las Vegas.

    During the session at SCAI 2012 session, the IHF Working Group will also outline its comprehensive multi-year plan to educate the field on this concept, in order to promote effective multi-disciplinary care for these patients.

    Find Out More About the IHF Working Group

    Back to Top


    SAVE THE DATE: SCAI-WIN 4th Annual Women in Interventional Cardiology

    Join SCAI Women in Innovations (SCAI-WIN) and program directors Kimberly A. Skelding, MD, FSCAI and Patricia Best, MD, FSCAI for the 4th Annual Women in Interventional Cardiology program, to be held September 20-22, 2012 at the Allerton Hotel in Chicago.

    Last year's program drew over 60 women, and this year's program looks to be the biggest and best yet! It will include top quality educational programming for both clinical cardiologists and private practice physicians on some of the field's hottest topics such as TAVR, radial interventions, FFR/IVUS/OCT, and left main stenting.

    Mix in a series of case-based programs and rotating workshops including hands-on simulation training, private practice development, clinical research development, and new technology training and you have the ingredients for a memorable and outstanding education program.

    Register Now

    Additional Information

    Back to Top


    In the Blink of an Eye-PAB: IPAB Repeal Bill Quickly Moves Forward

    The House Energy and Commerce Committee acted quickly and in a bipartisan manner to pass the IPAB repeal bill (HR 452) on Tuesday. In a letter sent to the Committee on February 24, SCAI and its Alliance of Specialty Medicine partners had urged the Committee to pass HR 452.

    Introduced by U.S. Representative Phil Roe (R-TN), the bill would repeal the Independent Payment Advisory Board (IPAB). SCAI has actively supported repeal of the IPAB because it would would have far too little accountability and the ability to make across-the-board Medicare cuts. The bill next moves to the Ways and Means Committee.

    Read the SCAI Comment Letter on HR 452

    Back to Top


    SCAI Past President Fields Interviews on TAVR Consensus Document

    Theheart.org, MedPage Today and TCTMD are among media outlets that covered publication of the SCAI/AATS/ACCF/STS expert consensus document on creating and maintaining TAVR programs. The document's lead author SCAI Past President Carl Tommaso, MD, FSCAI responded to requests for interviews, emphasizing the importance of cross-specialty collaboration and teamwork as this new technology is rolled out. "This is a technology in its infancy. Because of the sophistication and the complexity of the procedure, it requires a lot of different minds," said Dr. Tommaso.

    Download the Expert Consensus Document on TAVR

    Back to Top


    Attention Training Directors: Braden Award Nominations Due March 16

    SCAI is reminding interventional cardiology training program directors to nominate worthy fellows-in-training for the Gregory Braden Memorial Fellow of the Year Award. The application deadline is Friday, March 16.

    In August of 2007, SCAI Board of Trustees member Gregory Braden, MD, FSCAI tragically passed away. An active researcher, educator and friend to the Society, Dr. Braden was best known for his pioneering work in intravascular ultrasound (IVUS), coronary atherectomy, and chronic total occlusions. In keeping with his positive and generous spirit, Dr. Braden's friends and family have established the Gregory Braden Memorial Fund through the Forsyth Medical Center Foundation in Winston-Salem, NC.

    QUALIFICATIONS:
    As part of the fund's purpose, SCAI is honored to present the annual "Gregory Braden Memorial Fellow of the Year Award" to a graduating interventional cardiology fellow who best represents the following qualities that Dr. Braden exemplified:

    • Demonstrates excellent interventional skills in multiple CV modalities;
    • Shows promise for future contributions to CV research through publications or otherwise;
    • Consistently demonstrates dedication to patient care and patient well-being;
    • Shows potential to become a leader amongst peers; and
    • Strives to contribute to the overall advancement of interventional cardiology.

    The award recipient will be presented with a hand-crafted crystal award, a $2,500 cash award, and a one year free membership to SCAI post-graduation during the Annual Banquet at SCAI 2012 Scientific Sessions.

    Find Out More & Make Your Nominations

    Back to Top



    High-Risk PCI Online Curriculum Latest Addition to e-Learning Library

    SCAI's catalog of eLearning opportunities has expanded with the recent launch of the High-Risk Percutaneous Coronary Intervention (PCI) online course. Featuring an engaging combination of didactic presentations and case studies, the High-Risk PCI program fulfills members' requests for additional information about this critical area of interventional cardiology practice.

    This online course is designed to provide core education to physicians regardless of their experience level in this growing and changing area of interventional cardiology. In addition to covering case selection and management, the curriculum also covers device selection strategy as well as hemodynamics of such procedures. Led by Course Director Robert Applegate, MD, FSCAI, the program is presented by a world-class faculty representing leaders within the field.

    The High Risk PCI course is provided via an educational grant from Abiomed and is available to all fellows-in-training and practicing interventional cardiologists to access for free. In order to claim CME hours users can purchase individual modules or the full program. Each module is worth 1 CME hour and can be purchased for $20 by SCAI members. The full 8 CME hour program is $150 for members.

    Access SCAI's High-Risk PCI Online Curriculum

    Visit SCAI's eLearning Library

    Back to Top